Monday, 24 November 2025

Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says

Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says submitted by /u/cnn
[link] [comments]


from Health https://ift.tt/ve6DC3X
via IFTTT

No comments:

Post a Comment